Clinical life science solutions provider Bioclinica has expanded its portfolio of specialty software solutions with the addition of ‘Image Redact AI’ for clinical trials.

The new product will support the redaction of sensitive patient information from videos in addition to photos and PDFs in clinical trials.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Image Redact AI offers pharmaceutical and biotech companies a tool for redaction and ensures compliance and patient privacy.

Bioclinica chief innovation officer Dan Gebow said: “Image Redact AI is the latest demonstration of how we are delivering value to our customers using cutting-edge technology.

“Today, we can include videos in the long list of file types that our image de-identification system can handle with ease.”

Earlier, it was difficult to ensure videos fully comply with patient privacy regulations in clinical trials. This increased the risk of costly penalties and reputation damage for sponsors of clinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Bioclinica’s new AI application enables them to benefit from peace of mind and processing capabilities that cut down time to redact patient identifiers within videos.

The company’s launch of the new solution follows its acquisition of AI company Saliency.

Bioclinica Image Redact AI automatically redacts sensitive patient identifiers from videos, photos, and PDFs and safeguards sensitive clinical trial data.

By pairing AI-driven de-identification with the human oversight of an experienced quality control team, it will help ensure videos and photos comply with 21 CFR Part 11, EU GDPR, and other privacy regulations.

Image Redact AI pre-screens to ensure accurate file type and size before the submission of a video, photo, or PDF to the company’s 100% browser-based Global Cloud Network that is secure.

The technology then removes all sensitive patient information by performing the de-identification process.

This will be followed by a 100% human visual quality control review by Bioclinica technicians for proper de-identification prior to the availability of the data.